Literature DB >> 536356

Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment.

A Svedhem, S Iwarson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 536356     DOI： 10.1093/jac/5.6.717

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.

Authors:  Martha Nepka; Efstathia Perivolioti; Eleni Kraniotaki; Lida Politi; Athanasios Tsakris; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 3.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

4.  Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.

Authors:  D Torre; S Casari; F Speranza; A Donisi; G Gregis; A Poggio; S Ranieri; A Orani; G Angarano; F Chiodo; G Fiori; G Carosi
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

5.  In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

Authors:  D L Winslow; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

6.  Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.

Authors:  M N Dudley; R E Levitz; R Quintiliani; J M Hickingbotham; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

8.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.